DRUG RECALLS: JULY 2010
JULY 2010: QUALAQUIN (QUININE SULFATE) RECALLED DUE TO UNAPPROVED USES SUCH AS NIGHT TIME LEG CRAMPS, THIS DRUG MAY RESULT TO SERIOUS LIFE THREATENING HEMATOLOGICAL REACTIONS ALSO SERIOUS BLEEDING DUE TO THROMBOCYTOPENIA WHICH IN SOME CASES IT MAY RESULT TO PERMANENT KIDNEY DAMAGE. ADVERSE REACTIONS MAY RESULT TO HOSPITALIZATION & DEATH
JULY 2010: QUE SHE HERBAL WEIGHT LOSS SUPPLEMENT RECALLED DUE TO UNDECLARED DRUG INGREDIENTS THAT COULD HARM CONSUMERS ESPECIALLY THOSE WITH CARDIOVASCULAR CONDITIONS, THESE INGREDIENTS COULD INTERACT WITH OTHER MEDICATIONS & COULD CAUSE A SERIOUS ADVERSE EVENT
JULY 2010: ARAVA (LEFLUNOMIDE) FOR RHEUMATOID ARTHRITIS RECALLED DUE TO NEW INFORMATION ADDED IN BOX WARNING OF THE DRUG THAT IT HAS A RISK OF SEVERE LIVER INJURY
JULY 2010: COUMADIN 1MG TABLET BLISTER PACKS RECALLED DUE TO MANAGEABLE ACTIVE INGREDIENT ISOPROPANEL IN COUMADIN BECAUSE IT MAY NOT MEET SPECIFICATION. A DECREASE OF ACTIVE INGREDIENT MAY INCREASE THE RISK OF CLOTS WHICH CAN LEAD TO HEART ATTACK OR STROKE, AND IF THERE IS TOO MUCH OF ACTIVE INGREDIENT THERE CAN BE AN INCREASED RISK FOR BLEEDING
JULY 2010: ANGIOTENSIN RECEPTOR BLOCKERS (ARBs) RECALLED DUE TO A RECENT DRUG STUDY THAT SUGGESTED USE OF ARBs MAY BE ASSOCIATED WITH A SMALL INCREASED RISK OF CANCER
JULY 2010: CERTAIN ADVAIR DISKUS INHALERS WERE STOLEN FROM A DISTRIBUTION WAREHOUSE IN 2009 HAVE BEEN FOUND IN SOME PHARMACIES, THE SAFETY AND EFFECTIVENESS OF THE STOLEN INHALERS CANNOT BE ASSURED AND THEY SHOULD NOT BE USED
JULY 2010: SLIM-30 HERB SUPPLEMENT RECALLED DUE TO UNDECLARED DRUG INGREDIENT N-DESMETHYL SIBUTRAMINE THAT IS FOR WEIGHT LOSS. THIS INGREDIENT HAS NOT YET BEEN APPROVED BY THE FDA THEREFORE THE SAFETY & EFFECTIVENESS IS UNKNOWN. SIBUTRAMINE CAN INCREASE BLOOD PRESSURE & PULSE RATE IN PATIENTS WITH A HISTORY OF CONGESTIVE HEART FAILURE (CHF), CORONARY ARTERY DISEASE, ARRHYTHMIAS OR STROKE
JULY 2010: VIALIPRO DIETARY SUPPLEMENT RECALLED DUE TO UNDECLARED DRUG INGREDIENT SULFOAILDENAFIL AN ANALOGUE OF SILDENAFIL FOR MALE ERECTILE DYSFUNCTION. THE INGREDIENT MAY POSE A THREAT TO THE CONSUMERS BECAUSE THE INTERACTION OF THE ANALOGUE WITH PRESCRIPTION DRUGS SUCH AS NITROGLYCERIN MAY LOWER BLOOD PRESSURE IN DANGEROUS LEVELS
JULY 2010: CUBICIN (DAPTOMYCIN) AN INTRAVENOUS ANTIBACTERIAL DRUG INDICATED FOR USE IN TREATMENT OF SERIOUS SKIN INFECTIONS & BLOODSTREAM INFECTIONS RECALLED DUE TO POSSIBLE DEVELOPMENT OF EOSINOPHILIC PNEUMONIA DURING TREATMENT OF THIS DRUG. EOSINOPHILIC PNEUMONIA IS A RARE BUT SERIOUS CONDITION WHERE A TYPE OF WHITE BLOOD CELL (EOSINOPHIL) FILLS THE LUNGS, SYMPTOMS OF THIS CONDITION ARE FEVER, COUGH, SHORTNESS OF BREATH, & DIFFICULTY BREATHING. MAY LEAD TO RESPIRATORY FAILURE & POTENTIALLY FATAL IF NOT QUICKLY RECOGNIZED
JULY 2010: EVAMIST (ESTRADIOL) TRANSDERMAL SPRAY, AN ESTROGEN HORMONE USED TO REDUCE HOT FLASHES DURING MENOPAUSE RECALLED DUE TO CHILDREN UNINTENTIONALLY EXPOSED TO THE DRUG THROUGH SKIN CONTACT WITH WOMEN MAY EXPERIENCE PREMATURE PUBERTY. FEMALE CHILDREN MAY EXPERIENCE NIPPLE SWELLING & BREAST DEVELOPMENT. MALE CHILDREN MAY EXPERIENCE BREAST ENLARGEMENT
JULY 2010: MIRACLE MINERAL SOLUTION (MMS) AN ORAL LIQUID SOLUTION RECALLED DUE TO WHEN USED AS DIRECTED PRODUCES AN INDUSTRIAL BLEACH THAT CAN CAUSE SERIOUS HARM TO HEALTH. THE PRODUCT INSTRUCTS CONSUMERS TO MIX THE 28% SODIUM CHLORITE SOLUTION WITH AN ACID SUCH AS CITRUS JUICE, THIS MIXTURE PRODUCES CHLORINE DIOXIDE (A POTENT BLEACH USED FOR STRIPPING TEXTILES & INDUSTRIAL WATER TREATMENT), HIGH ORAL DOSES OF THE BLEACH CAN CAUSE NAUSEA, VOMITING, DIARRHEA, & SYMPTOMS OF SEVERE DEHYDRATION
